Hosted by Fondation-Merieux.
From the Fondation-Merieux website:
Vaccines are playing a major role in reducing the impact of infectious diseases. Nevertheless, vaccines have still to target important health problems. The development of individual viral proteins as vaccine candidates has met a limited success although these viral proteins were the targets of neutralizing antibodies mediating protection.
Alternative approaches are needed, and virus-like particles (VLPs) could contribute to progress in this regard.